- Zacks
Here's Why You Should Retain Inari Medical (NARI) for Now
Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
- Zacks
Veracyte (VCYT) Up 8.4% Since Last Earnings Report: Can It Continue?
Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Inari's (NARI) Expanding Product Portfolio Offsets Competition
Inari's (NARI) VTE products are driving its top line on the back of robust adoption. The company is expanding in additional indications to fuel growth and fight competition.
